Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/DRMA/Net margin

Dermata Therapeutics, Inc. (DRMA) Net margin

Dermata Therapeutics, Inc. (DRMA) net profit margin by fiscal year — reported net income divided by reported revenue.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to DRMA

Source: SEC XBRL filings · For reference only · Not investment advice

More DRMA financial trends

DRMA RevenueDRMA Net incomeDRMA Gross profitDRMA Gross marginDRMA Operating incomeDRMA Operating marginDRMA Operating cash flowDRMA Free cash flowDRMA Capital expendituresDRMA Return on equityDRMA Stock buybacksDRMA Dividends paidDRMA Total assetsDRMA Total liabilitiesDRMA Shareholders’ equityDRMA overview →